UroGen Pharma's potential remains strong despite market volatility, with promising FDA prospects for UGN-102 & a $5B ...

Hundreds will benefit after the first targeted treatment for the most common form of bladder cancer was given the green light ...

Hundreds of patients are expected to benefit from the recommendation by the National Institute of Health and Care Excellence.

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods ...

The oral drug – Johnson & Johnson's Balversa (erdafitinib) – will become an option for adults with metastatic or unresectable ...

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods ...

Hundreds will benefit after the first targeted treatment for the most common form of bladder cancer was given the green light ...

The investigational therapy combines mRNA technology with immunotherapy to train the immune system to target cancer cells ...

Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary ...

A groundbreaking targeted treatment for the most common type of bladder cancer has been approved for use by the NHS, offering new hope to hundreds of patients. The National Institute of Health and ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...